drugset / Trial / NCT03133676
A Study Evaluating the Safety, Pharmacokinetics, and Pharmacodynamics of KA34 in Subjects With Knee Osteoarthritis
Phase 1
Completed
60 enrolled
Calibr, a division of Scripps Research
California Institute for Regenerative Medicine (CIRM) · collab
RandomizedParallel-groupDouble-blindTreatment
Summary
This study will evaluate the safety and tolerability of KA34 when administered via intra-articular injection to subjects with osteoarthritis of the knee.
Timeline
- Start
- 2018-05-02
- Primary completion
- 2020-04-28
- Completion
- 2020-04-28
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | KA34 | Unknown | — | Other |